Dimensional Fund Advisors
OREX

Dimensional Fund Advisors’s Orexigen Therapeutics, Inc. OREX Stock Holding History

Dimensional Fund Advisors’s Portfolio OREX Stock Details OREX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-70
Closed -$4K – 3541
2014
Q4 		$4K Hold
70
– – ﹤0.01% 3491
2014
Q3 		$3K Hold
70
– – ﹤0.01% 3532
2014
Q2 		$4K Hold
70
– – ﹤0.01% 3571
2014
Q1 		$5K Hold
70
– – ﹤0.01% 3575
2013
Q4 		$4K Hold
70
– – ﹤0.01% 3522
2013
Q3 		$4K Hold
70
– – ﹤0.01% 3554
2013
Q2 		$4K Buy
+70
New +$4.31K ﹤0.01% 3562

Other funds holding OREX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
FCMI
Foresite Capital Management II Larkspur, California $29.2M AUM 44.84% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Dimensional Fund Advisors's OREX Position: Q1 2015 in Review

Dimensional Fund Advisors sold out of Orexigen Therapeutics, Inc. (OREX) in Q1 2015, closing a stake of 70 shares — an estimated $4K sold.

Dimensional Fund Advisors first reported a position in OREX in Q2 2013 and held it in 7 quarters. The position peaked at $5K in Q1 2014. 160 funds tracked by Wall St. Rank hold OREX as of Q1 2015.

  • Dimensional Fund Advisors reported no remaining Orexigen Therapeutics, Inc. position as of Q1 2015 after selling out during the quarter.
  • Dimensional Fund Advisors sold 70 Orexigen Therapeutics, Inc. shares in Q1 2015, an estimated $4K.
  • Dimensional Fund Advisors first reported a position in Orexigen Therapeutics, Inc. in Q2 2013 and held it in 7 quarters.
  • Dimensional Fund Advisors's Orexigen Therapeutics, Inc. position peaked at $5K in Q1 2014.
  • 160 funds tracked by Wall St. Rank held Orexigen Therapeutics, Inc. as of Q1 2015.

Based on Dimensional Fund Advisors's 13F filing for Q1 2015, filed 14 May 2015.